The FDA added two new warnings to statin drugs this week. These warnings include an increased risk of diabetes and mental confusion among statin users. The FDA report said that all statin labeling must carry warnings about increased risk of elevated blood sugar and transient memory loss and cognitive problems. Read more
No comments:
Post a Comment
Your comments are welcomed, but they will not be posted until they are read and approved. Please do not try to post the same comment multiple times.